ENDOCRINE JOURNAL《内分泌杂志》(可网站投稿)

Endocrine Journal(月刊)。Our official Japanese journal “Naibunpigaku Zasshi” was first issued in 1925 and renamed as “Nihon Naibunpigaku-kai Zasshi” in 1927. In 1954 the first issue of English official journal “Endocrinologia Japonica” was published continuing to Volume 39 in 1992 and then renamed as the present “Endocrine Journal” from Volume 40 in 1993.

杂志简称:endocr j
中文译名:《内分泌杂志》
收录属性:scie(2024版), 目次收录(维普),英文期刊,
自引率:3.00%
投稿方向:医学、endocrinology & metabolism内分泌学与代谢

ENDOCRINE JOURNAL《内分泌杂志》

SCI/E期刊基本信息

出版周期:月刊 地区:日本
中科院分区:4区
是否TOP:非TOP期刊
是否综述:非综述期刊
是否OA:OA期刊
国际标准刊号:ISSN 0918-8959/EISSN 1348-4540
杂志语言:英语
出版国家:日本

杂志官网 联系方式

出版地址:75YANAGINOBANBA NISHIIRU-MASUYA-CHO,SANJOU-DORI,NAKAGYOU-KU,KYOTO,JAPAN,604-8111
杂志邮箱:
投稿网址:http://mc.manuscriptcentral.com/endocrj
杂志官方网址:https://www.jstage.jst.go.jp/browse/endocrj/
出版商网址:https://www.jstage.jst.go.jp/browse/-char/en

杂志投稿要求

投稿须知

【杂志社官方网站信息】

INSTRUCTIONS FOR AUTHORS

(December 2020)

Manuscript Types and Submission Procedure

1. Manuscript types: Original Articles, Notes, Rapid Communications, Reviews and Letters to the Editor. Original Articles should be novel and original research reports. Brief manuscripts reporting data that are preliminary, negative or confirmatory, but have significant relevance should be published as Notes. Rapid Communications that are no longer than four printed pages (about 2,000 words for the Body Text) should be of sufficient significance to be published immediately.

For Case Reports, EJ will only accept those of great significance or those with an original point of view as Original Articles or Notes. EJ will not receive Case Reports as Letters to the Editor.

For Reviews and Letters to the Editor, refer to the following sections on Review Articles and Letters to the Editor.

2. Submission Procedure: EJ will receive Manuscripts submitted via the J-STAGE electronic online submission system: (J-STAGE 3 (http://mc.manuscriptcentral.com/endocrj).

At the Initial Submission of the Manuscript, each manuscript must be accompanied by a Cover Letter to the Editor-in-Chief.

The Cover Letter to the Editor-in-Chief should state the author’s wish that the submission be reviewed for publication in EJ, include the background of the submission, the significance of the investigative report, a declaration of originality, and state that the manuscript has not been submitted to any other journal. When submitting again a manuscript that has been submitted to EJ previously and decided Reject, or when submitting a manuscript that is closely related to a manuscript that has been previously submitted, include the manuscript ID of the previous or related submission and describe the background in the Cover Letter. When submitting again a manuscript that was submitted to EJ previously, its author is requested to upload not only Cover Letter to the Editor-in-Chief, which includes Manuscript ID and History of the previously submitted manuscript, but also a Response Letter to the Editor and Reviewers’ comments to the previous manuscript, created in accordance with the procedure of the below 14. Revision of the manuscript and creation of a Response Letter. In the newly submitted manuscript, revised sentences and paragraphs must be highlighted.

Preparation of the Manuscript (cf. Checklist on page five)

The Manuscript File (Main Document/Word file) should include all of the following items (from 1. Title to 7. References). The Table File and Figure File should be uploaded as separate individual files. The uploaded Manuscript File, Table File and Figure File will be converted into a PDF file automatically. Author should check the PDF file whereby the manuscript undergoes a peer review process. Prepare the Body Text using Times New Roman font, a font size of 12 and double spacing. To facilitate review process, successive line numbers should be indicated on all pages.

1. Titles: Titles should be concise, specific, informative and clear and should emphasize the main point of the article.

Abbreviations should be spelled out (eg., type 2 diabetes (T2D)).

2. Running Head: A short form of the Title not exceeding 40 letters including spaces.

3. Author: Authors’ names should be listed in the following order: given name first and then family name. Include each author’s full name, and the address and ZIP code of the institution where the study was performed. Persons who made supplementary contributions may be listed in “Acknowledgements.” A complete mailing address (Street No., ZIP code) and E-mail address for the Corresponding Author should be given on the title page.

Authorship: EJ does not allow online submission by a third party. An automatic email notifying successful submission is to be sent to Corresponding author and to all co-authors for confirmation of their agreement to submission. Corresponding author is notified and requested to enter all co-authors’ names and their correct email addresses if he/she fails to enter them at the initial submission, or if any automatic email has returned to the Office as an undeliverable email. The Office will not receive a manuscript if there is any incorrect entry of email address data. The address should be valid.

刊知网 精心整理,转载请注明出处:https://www.kanzhiwang.com/archives/40135

我要点评 请您把投稿经验分享出来 让大家少走弯路少踩坑,我为人人、人人为我。

内容纠错 杂志信息如有错漏 请在下方留言。

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS《内分泌,代谢与免疫疾病-药物靶点》(可邮箱和网站投稿)
上一篇 2025年2月15日 下午1:29
Revue scientifique et technique-OFFICE INTERNATIONAL DES EPIZOOTIES《科学与技术评论》(可邮箱投稿)
下一篇 2025年2月15日 下午1:33

相关推荐

发表回复

登录后才能评论

联系我们

191 1833 1195

QQ:321628655
邮件:321628655@qq.com

工作时间:周一至周五,9:30-18:30,节假日休息